Mr. Robert Louie is a pharmacist who is specialized in Oncology in Astoria, New York. Patients can reach him at 3175 23rd St, Suite 410, Astoria or contact him on 800-350-8119. Active license number of Mr. Robert Louie is 039477 for Oncology in New York. Mr. Robert Louie is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Mr. Robert Louie speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mr. Robert Louie
Specialization:
Oncology
Credentials:
RPH
Gender:
Male
Location:
3175 23rd St, Suite 410, Astoria, New York, 11106-4134
Phone:
800-350-8119
Fax:
800-349-5058
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Robert Louie are as mentioned below.
NPI Number:
1447419395
NPI Enumeration Date:
05 Jun, 2008
NPI Last Update On:
05 Jun, 2008
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Robert Louie are as mentioned below.
Specialization
License Number
State
Status
Oncology
039477
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3175 23rd St, Suite 410 Astoria, New York
Zip:
11106-4134
Phone Number:
800-350-8119
Fax Number:
800-349-5058
Patients can reach Mr. Robert Louie at 3175 23rd St, Suite 410, Astoria, New York or can call on phone at 800-350-8119.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.